2013-11-08T14:28:25-06:00 2012-12-31 420714325 MCGLADREY LLP 8000 TOWERS CRESCENT DR STE 500 VIENNA VA 221826205 990 2012-01-01 521006053 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION ADVA 2027838700 701 PENNSYLVANIA AVENUE NW NO 800 WASHINGTON DC 200042654 KENNETH MENDEZ 2027838700 2013-11-07 1 YONG ZHANG CPA P01249785 7033366400 2012 2016-02-24 21:20:13Z ADVAMED STEPHEN J UBL 701 PENNSYLVANIA AVENUE NW NO 800 WASHINGTON DC 200042654 30615049 0 X WWW.ADVAMED.ORG X 1974 DE TO REPRESENT THE INTERESTS OF MANUFACTURERS OF VARIOUS MEDICAL DEVICES, DIAGNOSTIC PRODUCTS, AND MEDICAL INFORMATION SYSTEMS. 40 40 94 0 0 0 0 0 29616258 29886961 418559 555242 194554 172846 30229371 30615049 142266 163896 0 0 15646116 16413322 0 0 0 13817726 13869441 29606108 30446659 623263 168390 13575958 13291335 7095818 6642805 6480140 6648530 X ADVAMED ADVOCATES FOR A LEGAL, REGULATORY, AND ECONOMIC ENVIRONMENT THAT ADVANCES GLOBAL HEALTH CARE BY ASSURING WORLDWIDE PATIENT ACCESS TO THE BENEFITS OF MEDICAL TECHNOLOGY. WE PROMOTE POLICIES THAT FOSTER THE HIGHEST ETHICAL STANDARDS, RAPID APPROVAL OF SAFE AND EFFECTIVE PRODUCTS, ADEQUATE REIMBURSEMENT, AND ACCESS TO INTERNATIONAL MARKETS. 0 0 ADVAMED'S GOVERNMENT AFFAIRS FUNCTION REPRESENTS THE INDUSTRY BEFORE STATE AND FEDERAL POLICYMAKERS, IN GOVERNOR'S OFFICES, STATE LEGISLATURES, THE UNITED STATES CONGRESS, AND RELEVANT FEDERAL AGENCIES. ADVAMED'S ADVOCACY STAFF AND OUTSIDE CONSULTANTS PROVIDE INFORMATION ON POLITICAL AND POLICY DEVELOPMENTS, AND PURSUE THE INDUSTRY'S AGENDA FOR A LEGAL, REGULATORY AND ECONOMIC ENVIRONMENT THAT ADVANCES HEALTH CARE BY ASSURING PATIENT ACCESS TO THE BENEFITS OF MEDICAL TECHNOLOGY. TAKING MEMBER COMPANY FEEDBACK FROM WORKING GROUPS AND COMMITTEES,ADVAMED STAFF PROVIDE CRITICAL INPUT TO REGULATORY AGENCIES LIKE FDAAND CMS ON REGULATIONS AND RULES THAT IMPACT THE ABILITY FOR PATIENTSTO RECEIVE TIMELY ACCESS TO LIFE CHANGING DEVICES PRODUCED BY ADVAMED MEMBERS. OUR CONSULTANTS IN JAPAN, CHINA, AND OTHER OVERSEAS MARKETS REPRESENT ADVAMED IN RAPIDLY EXPANDING OVERSEAS MARKETS AND ATTEND MEETINGS WITH GOVERNMENT OFFICIALS AND INDUSTRY COMMITTEE MEETINGS. THESE CONSULTANTS PROVIDE REAL-TIME INFORMATION AND AN INDUSTRY VOICE IN OVERSEAS MARKETS. 0 0 0 1 0 0 0 0 0 1 0 0 0 1 1 0 1 0 1 1 1 0 0 0 0 0 1 0 1 0 1 0 0 0 0 0 0 0 0 0 1 1 1 0 1 88 0 1 94 1 0 1 JA 0 0 0 0 X 40 40 0 0 0 0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 X JENNIFER BREAREY 2027838700 701 PENSYLVANIA AVE NW STE 800 WASHINGTON DC 200042654 DAVID DVORAK 1.00 X X 0 0 0 JOE ALMEIDA 1.00 X X 0 0 0 DAVID PEREZ 1.00 X X 0 0 0 PETER ARDUINI 1.00 X 0 0 0 MICHAEL BALL 1.00 X 0 0 0 JOANNE BAUER 1.00 X 0 0 0 JEFFREY BINDER 1.00 X 0 0 0 KEVIN BUEHLER 1.00 X 0 0 0 DONALD CASEY 1.00 X 0 0 0 ROBERT M DAVIS 1.00 X 0 0 0 JOSEPH DEVIVO 1.00 X 0 0 0 ROLAND DIGGELMANN 1.00 X 0 0 0 DEBORAH DISANZO 1.00 X 0 0 0 CAMILLE FARHAT 1.00 X 0 0 0 MAURICE FERRE 1.00 X 0 0 0 CAMERON FINDLAY 1.00 X 0 0 0 VINCENT A FORLENZA 1.00 X 0 0 0 MICHAEL FRAZZETTE 1.00 X 0 0 0 KIERAN T GALLAHUE 1.00 X 0 0 0 JOHN GREISCH 1.00 X 0 0 0 TIMOTHY E GUERTIN 1.00 X 0 0 0 JORGEN HANSEN 1.00 X 0 0 0 THOMAS HOOK 1.00 X 0 0 0 LESTER KNIGHT 1.00 X 0 0 0 KAREN LICITRA 1.00 X 0 0 0 KEVIN LOBO 1.00 X 0 0 0 DAVID L LUCCHINO 1.00 X 0 0 0 MICHAEL MAHONEY 1.00 X 0 0 0 ALAN MAIN 1.00 X 0 0 0 V GEORGE MALIEKEL 1.00 X 0 0 0 JAMES V MAZZO 1.00 X 0 0 0 STEPHEN F MEYER 1.00 X 0 0 0 MICHAEL R MINOGUE 1.00 X 0 0 0 MICHAEL A MUSSALLEM 1.00 X 0 0 0 CAROLL NEUBAUER 1.00 X 0 0 0 STUART A RANDLE 1.00 X 0 0 0 DEBRA RECTENWALD 1.00 X 0 0 0 TIMOTHY M RING 1.00 X 0 0 0 WALTER M ROSEBROUGH 1.00 X 0 0 0 VIRGINIA RYBSKI 1.00 X 0 0 0 BRENT SAUNDERS 1.00 X 0 0 0 NADIM YARED 1.00 X 0 0 0 STEPHEN J UBL 40.00 X 1810789 0 47553 CHRISTOPHER L WHITE 40.00 X 597985 0 41973 KENNETH MENDEZ 40.00 X 469444 0 41973 JENNIFER BRANDELY 40.00 X 174825 0 16320 RALPH IVES 40.00 X 408317 0 30779 ANN-MARIE LYNCH 40.00 X 482147 0 30779 ANDREW FISH 40.00 X 502090 0 39301 DAVID NEXON 40.00 X 573901 0 30577 JANET TRUNZO 40.00 X 485450 0 38173 FRANK WILTON 40.00 X 297097 0 42018 JUAN CARLOS SCOTT 40.00 X 468747 0 38444 GARY KARR 40.00 X 349005 0 41973 PHILIP AGRESS 40.00 X 287411 0 29042 RICHARD PRICE 40.00 X 273932 0 35859 STEVEN BROTMAN 40.00 X 335903 0 40219 ELIZABETH PIKA SHARP 40.00 X 265403 0 32651 ELIZABETH KEGLER 40.00 X 261087 0 32507 MARTYN HOWGILL 0.00 X 210142 0 0 8253675 0 610141 33 1 1 0 NEIMAND COLLABORATIVE INC 1025 VERMONT AVENUE NW STE 830 WASHINGTON DC 20005 CONSULTING/ MONTHLY RETAINER 764264 PURPLE STRATEGIES 815 SLATERS LANE ALEXANDRIA VA 22314 CONSULTING/ MONTHLY RETAINER 482173 ALBRIGHT STONEBRIDGE GROUP LLC 555 13TH ST NW STE 300 W WASHINGTON DC 20004 CONSULTING/ MONTHLY RETAINER 336943 LATHAM & WATKINS LLP 555 ELEVENTH ST NW STE 1000 WASHINGTON DC 20004 CONSULTING/ MONTHLY RETAINER 325759 CROWELL & MORING INTERNATIONAL LP 1001 PENNSYLVANIA AVE NW WASHINGTON DC 20004 CONSULTING/ MONTHLY RETAINER 300768 25 MEMBERSHIP DUES 900099 27589040 27589040 SEMINARS 611430 2062251 2062251 SPECIAL PROJECTS 900099 235670 235670 29886961 555242 555242 110393 110393 OTHER INCOME 900099 50453 50453 ADMIN. FEES REVENUE 900099 12000 12000 62453 30615049 29898961 0 716088 X 148270 15626 7059659 7287558 530977 897713 637415 589466 62175 1814014 4826853 11916 755002 199508 1531264 1391251 1415995 541855 66883 DUES & SUBSCRIPTION 377941 OTHER EXPENSES 185209 TRAINING 100109 30446659 1371 717 10060436 9493477 66655 183977 1173 3434 209409 569444 5015651 3455727 1913978 1559924 852971 1014194 469965 466168 13575958 13291335 4305761 3948473 2322283 2444919 467774 249413 7095818 6642805 X 6480140 6648530 6480140 6648530 13575958 13291335 168390 0 X X 0 1 X 1 0 0 0 1 27589040 1814014 -96008 1718006 1655342 62664 2234786 1386100 848686 2015018 1594635 420383 765847 474992 290855 1559924 DEFERRED ASSESSMENTS 206897 CAPITAL LEASE OBLIGATION 42516 249413 X 30792518 177469 177469 30615049 0 30615049 32549134 2102475 2102475 30446659 0 30446659 DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48: PART X, LINE 2: ADVAMED COMPLIES WITH THE ACCOUNTING STANDARD ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES, WHICH ADDRESSES THE DETERMINATION OF WHETHER TAX BENEFITS CLAIMED OR EXPECTED TO BE CLAIMED ON A TAX RETURN SHOULD BE RECORDED IN THE FINANCIAL STATEMENTS. UNDER THIS GUIDANCE, ADVAMED MAY RECOGNIZE THE TAX BENEFIT FROM AN UNCERTAIN TAX POSITION ONLY IF IT IS MORE LIKELY THAN NOT THAT THE TAX POSITION WILL BE SUSTAINED ON EXAMINATION BY TAXING AUTHORITIES, BASED ON THE TECHNICAL MERITS OF THE POSITION. THE TAX BENEFITS RECOGNIZED IN THE FINANCIAL STATEMENTS FROM SUCH A POSITION ARE MEASURED BASED ON THE LARGEST BENEFIT THAT HAS A GREATER THAN 50% LIKELIHOOD OF BEING REALIZED UPON ULTIMATE SETTLEMENT. THE GUIDANCE ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES ALSO ADDRESSES DE-RECOGNITION, CLASSIFICATION, INTEREST AND PENALTIES ON INCOME TAXES, AND ACCOUNTING IN INTERIM PERIODS. ADVAMED HAD NO SUCH POSITIONS RECORDED IN THE FINANCIAL STATEMENTS AT DECEMBER 31, 2012. GENERALLY, ADVAMED IS NO LONGER SUBJECT TO U.S. FEDERAL INCOME TAX POSITIOS BY TAX AUTHORITIES FOR YEARS BEFORE 2009. PART XI, LINE 2D - OTHER ADJUSTMENTS: INHEALTH REVENUE IN CONSOLIDATING FINANCIAL STATEMENTS 6,681. ADVAMED PAC REVENUE IN CONSOLIDATING FINANCIAL STATEMENTS 155,288. ADVAMED CA PAC REVENUE IN CONSOLIDATING FINANCIAL STATEMENTS 15,500. PART XII, LINE 2D - OTHER ADJUSTMENTS: INHEALTH EXPENSE IN CONSOLIDATING FINANCIAL STATEMENTS 1,941,360. ADVAMED PAC EXPENSE IN CONSOLIDATING FINANCIAL STATEMENTS 155,115. ADVAMED CA PAC EXPENSE IN CONSOLIDATING FINANCIAL STATEMENTS 6,000. 1 SOUTH AMERICA 0 0 GRANTMAKING 8045 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTMAKING 7581 EAST ASIA AND THE PACIFIC 1 3 PROGRAM SERVICES CONSULTANT IN ASIA MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 519620 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 182552 EUROPE (INCLUDING ICELAND & GREENLAND) 0 10 PROGRAM SERVICES CONSULTANT IN EUROPE MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 434911 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 127792 EUROPE (INCLUDING ICELAND & GREENLAND) 0 2 PROGRAM SERVICES MEETINGS TO PROMOTE THE HARMONIZATION OF INTERNATIONAL STANDARDS 318428 SOUTH AMERICA 0 1 PROGRAM SERVICES CONSULTANT IN BRAZIL MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 174206 SOUTH AMERICA 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 49915 SOUTH ASIA 0 1 PROGRAM SERVICES CONSULTANTS IN INDIA MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 77480 SOUTH ASIA 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 27318 1 16 0 1 1 17 1773135 154713 1927848 SOUTH AMERICA PROGRAM SUPPORT 8045 WIRE TRANSFER EUROPE (INCLUDING ICELAND & GREENLAND) PROGRAM SUPPORT 7581 WIRE TRANSFER 2 0 0 0 0 0 0 0 PROCEDURE FOR MONITORING GRANTS OUTSIDE THE U.S.: SCHEDULE F, PART I, LINE 2: ADVAMED BUDGETS ANNUALLY FOR CHARITABLE DONATIONS AND OTHER CHARITABLE GIVING THAT IS CLOSELY ALIGNED WITH ITS STRATEGIC PLAN AND MISSION. IN ADDITION, ADVAMED MAY IDENTIFY CAUSES THROUGHOUT THE YEAR THAT MAY REQUIRE REPURPOSING OF FUNDS FROM ANOTHER EXPENSE CATEGORY TO SUPPORT CERTAIN MEDICAL DEVICE ISSUES OR MEMBERSHIP INITIATIVES. ALL SUCH SPENDING IS PROCESSED THROUGH ADVAMED'S PURCHASE ORDER SYSTEM, WHICH REQUIRES SEVERAL LEVELS OF EXECUTIVE APPROVAL BEFORE ANY FUNDING IS MADE. 1 AMERICAN ASSOCIATION OF PEOPLE WITH DISABILITIES 1629 K STREET NW STE 950 WASHINGTON DC 20006 521930174 501(C)(3) 7000 PROGRAM SUPPORT NATIONAL HEALTH COUNCIL 1730 M STREET NW STE 500 WASHINGTON DC 20036 131624107 501(C)(3) 7000 PROGRAM SUPPORT WOMENHEART 818 18TH STREET NW STE 930 WASHINGTON DC 20006 522148006 501(C)(3) 7500 PROGRAM SUPPORT ALLIANCE FOR AGING RESEARCH 2021 K STREET NW STE 305 WASHINGTON DC 20006 541379174 501(C)(3) 10000 PROGRAM SUPPORT DXINSIGHTS 1822 EAST INNOVATION PARK DRIVE ORO VALLEY AZ 85755 501(C)(3) 10000 PROGRAM SUPPORT SOCIETY FOR WOMEN'S HEALTH RESEARCH 1828 L STREET NW STE 625 WASHINGTON DC 20036 521694732 501(C)(3) 10000 PROGRAM SUPPORT 6 0 PROCEDURE FOR MONITORING GRANTS IN THE U.S.: PART I, LINE 2: SCHEDULE I, PART I, LINE 2: ADVAMED BUDGETS ANNUALLY FOR CHARITABLE DONATIONS AND OTHER CHARITABLE GIVING THAT IS CLOSELY ALIGNED WITH ITS STRATEGIC PLAN AND MISSION. IN ADDITION, ADVAMED MAY IDENTIFY CAUSES THROUGHOUT THE YEAR THAT MAY REQUIRE REPURPOSING OF FUNDS FROM ANOTHER EXPENSE CATEGORY TO SUPPORT CERTAIN MEDICAL DEVICE ISSUES OR MEMBERSHIP INITIATIVES. ALL SUCH SPENDING IS PROCESSED THROUGH ADVAMED'S PURCHASE ORDER SYSTEM, WHICH REQUIRES SEVERAL LEVELS OF EXECUTIVE APPROVAL BEFORE ANY FUNDING IS MADE. X X X 1 1 X X X X 1 0 0 STEPHEN J UBL 1047240 0 721844 0 41705 0 29197 0 18356 0 1858342 0 0 0 CHRISTOPHER L WHITE 493525 0 103650 0 810 0 29197 0 12776 0 639958 0 0 0 KENNETH MENDEZ 385859 0 82775 0 810 0 29197 0 12776 0 511417 0 0 0 JENNIFER BRANDELY 157368 0 17250 0 207 0 16320 0 0 0 191145 0 0 0 RALPH IVES 349678 0 55075 0 3564 0 29197 0 1582 0 439096 0 0 0 ANN-MARIE LYNCH 416449 0 65550 0 148 0 29197 0 1582 0 512926 0 0 0 ANDREW FISH 426240 0 75310 0 540 0 26322 0 12979 0 541391 0 0 0 DAVID NEXON 483485 0 87000 0 3416 0 29197 0 1380 0 604478 0 0 0 JANET TRUNZO 376811 0 105075 0 3564 0 29197 0 8976 0 523623 0 0 0 FRANK WILTON 252054 0 44300 0 743 0 29197 0 12821 0 339115 0 0 0 JUAN CARLOS SCOTT 399661 0 68600 0 486 0 29197 0 9247 0 507191 0 0 0 GARY KARR 303370 0 44825 0 810 0 29197 0 12776 0 390978 0 0 0 PHILIP AGRESS 247654 0 37475 0 2282 0 29042 0 0 0 316453 0 0 0 RICHARD PRICE 224369 0 43800 0 5763 0 26098 0 9761 0 309791 0 0 0 STEVEN BROTMAN 281586 0 53075 0 1242 0 29025 0 11194 0 376122 0 0 0 ELIZABETH PIKA SHARP 232748 0 32175 0 480 0 27282 0 5369 0 298054 0 0 0 ELIZABETH KEGLER 228823 0 31800 0 464 0 26994 0 5513 0 293594 0 0 0 MARTYN HOWGILL 0 0 0 0 210142 0 0 0 0 0 210142 0 0 0 PART I, LINE 1A FIRST CLASS TRAVEL IS AUTHORIZED ONLY IN EXCEPTIONAL CIRCUMSTANCES, SUCH AS WHEN IT IS NECESSARY TO TAKE A SPECIFIC FLIGHT WHERE BUSINESS OR COACH CLASS IS NOT AVAILABLE, AND MUST FIRST HAVE PRIOR WRITTEN APPROVAL BY DEPARTMENT HEADS AND ADVAMED'S PRESIDENT. OTHER EXPENSES INCURRED BY THE TRAVELER FOR TRAVEL OUTSIDE THE DEFINITION OF A BUSINESS TRIP, INCLUDING EXPENSES FOR FAMILY MEMBERS TRAVELING WITH THE EMPLOYEE, ARE ALSO THE RESPONSIBILITY OF THE TRAVELER AND NOT ADVAMED. SUCH EXPENSES ARE KEPT SEPARATE FROM REIMBURSABLE BUSINESS EXPENDITURES. PERSONAL TRAVEL FOR FAMILY MEMBERS/FRIENDS MAY BE BOOKED THROUGH ADVAMED'S TRAVEL AGENCY BUT ARE IDENTIFIED SEPARATELY AND BILLED DIRECTLY TO THE EMPLOYEE. DUE TO THE FREQUENT TRAVEL SCHEDULE AND DEMANDS ON TIME REQUIRED BY THE POSITION, THE PRESIDENT OF ADVAMED MAY TRAVEL BUSINESS CLASS ON ALL INTERNATIONAL FLIGHTS AND FOR TRAVEL OVER 4 HOURS, WHERE SUCH SEATING IS AVAILABLE. SPOUSE'S TRAVEL WILL BE REIMBURSED ONLY WHERE SPOUSE'S ATTENDANCE IS REQUIRED FOR BUSINESS PURPOSES. TRAVEL IS NOT INCLUDED IN TAXABLE INCOME. ADVAMED'S CEO RECEIVED NONTAXABLE SOCIAL CLUB DUES AT THE AMOUNT OF $5,580 DURING 2012. PART I, LINE 4A MARTYN HOWGILL RECEIVED A SEVERANCE PAYMENT UNDER A CONFIDENTIAL AGREEMENT IN THE AMOUNT OF $ $210,142. ANDREW FISH PART V PART V X 2000 1656 0 0 1 CHRIS WHITE PART V PART V X 2000 1778 0 0 1 3434 SCHEDULE L, PART II, LOANS TO AND FROM INTERESTED PERSONS: (A) NAME OF PERSON: ANDREW FISH(B) RELATIONSHIP WITH ORGANIZATION: EXEC DIRECTOR, ADVAMEDDX(C) PURPOSE OF LOAN: COMPUTER LOAN(D) LOAN TO OR FROM ORGANIZATION? = FROM(E) ORIGINAL PRINCIPAL AMOUNT $ 2,000 (F) BALANCE DUE $ 1,656(G) LOAN IN DEFAULT? = NO(H) APPROVED BY BOARD OR COMMITTEE? = NO(I) WRITTEN AGREEMENT? = YES (A) NAME OF PERSON: CHRISTOPHER WHITE(B) RELATIONSHIP WITH ORGANIZATION: SR. EXEC VP & GENERAL COUNSEL(C) PURPOSE OF LOAN: COMPUTER LOAN(D) LOAN TO OR FROM ORGANIZATION? = FROM(E) ORIGINAL PRINCIPAL AMOUNT $ 2,000 (F) BALANCE DUE $ 1,778(G) LOAN IN DEFAULT? = NO(H) APPROVED BY BOARD OR COMMITTEE? = NO(I) WRITTEN AGREEMENT? = YES FORM 990, PART VI, SECTION A, LINE 6 THE ASSOCIATION HAS TWO CLASSES OF MEMBERSHIPS - ACTIVE AND ASSOCIATE. ANY FIRM OR CORPORATION WHICH, THROUGH ITSELF OR THROUGH ANY OF ITS SUBSIDIARIES OR DIVISIONS, IS SIGNIFICANTLY ENGAGED IN THE MANUFACTURE OF AND/OR THE RESEARCH WITH THE INTENT TO MANUFACTURE MEDICAL DEVICES, DIAGNOSTIC PRODUCTS AND/OR HEALTH CARE INFORMATION SYSTEMS WITHIN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS, SHALL BE ELIGIBLE FOR ACTIVE MEMBERSHIP. ANY COMPANY OR ORGANIZATION MAY BE ELIGIBLE AS AN ASSOCIATE MEMBER, IN ACCORDANCE WITH SUCH RULES AND REGULATIONS AS THE BOARD OF DIRECTORS OF THE ASSOCIATION MAY ADOPT ESTABLISHING A CLASS OR CLASSES OF ASSOCIATE MEMBERS AND DETERMINING ELIGIBILITY FOR MEMBERSHIP IN SUCH CLASS OR CLASSES. ASSOCIATE MEMBERS MAY PARTICIPATE IN SUCH AFFAIRS OF THE ASSOCIATION AS MAY BE DETERMINED BY THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION A, LINE 7A EACH ACTIVE MEMBER IN GOOD STANDING SHALL BE ENTITLED TO ONE VOTE ON ANY QUESTION COMING BEFORE THE GENERAL MEMBERSHIP, INCLUDING THE ELECTION OF THE BOARD OF DIRECTORS ANNUALLY. THE BOARD NOMINATING AND GOVERNANCE COMMITTEE PRESENTS A PROPOSED SLATE OF DIRECTORS BI-ANNUALLY TO THE MEMBERSHIP FOR VOTE. EACH ACTIVE MEMBER SHALL, IN WRITING, DESIGNATE ITS OFFICIAL REPRESENTATIVE TO VOTE AND REPRESENT THAT MEMBER IN ALL OF THE AFFAIRS OF THE ASSOCIATION, INCLUDING THE HOLDING OF OFFICE. FORM 990, PART VI, SECTION A, LINE 7B EACH ACTIVE MEMBER IN GOOD STANDING SHALL BE ENTITLED TO ONE VOTE ON ANY QUESTION COMING BEFORE THE GENERAL MEMBERSHIP. EACH ACTIVE MEMBER SHALL, IN WRITING, DESIGNATE ITS OFFICIAL REPRESENTATIVE TO VOTE AND REPRESENT THAT MEMBER IN ALL OF THE AFFAIRS OF THE ASSOCIATION, INCLUDING THE HOLDING OF OFFICE. SUCH OFFICIAL REPRESENTATIVE SHALL BE THE CHIEF EXECUTIVE OFFICER OR CHIEF OPERATING OFFICER OF THE MEMBER OR SUCH OTHER SENIOR OPERATING OFFICER AS THE CHIEF EXECUTIVE OFFICER MAY DESIGNATE. FORM 990, PART VI, SECTION B, LINE 11 AT ITS MEETING IN DECEMBER 2008, THE BOARD OF DIRECTORS RESOLVED TO DELEGATE ITS AUTHORITY FOR THE REVIEW AND APPROVAL OF THE FORM 990 TO THE BOARD COMMITTEE ON FINANCE, AUDIT AND COMPENSATION (FAC). THE FAC REVIEWS THE 990 FILING BEFORE IT IS MADE WITH THE IRS. THE DRAFT OF THE FORM 990 IS MADE AVAILABLE FOR REVIEW BY ALL BOARD MEMBERS ON THE BOARD OF DIRECTORS SECTION OF ADVAMED'S WEBSITE PRIOR TO FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C ADVAMED HAS IN PLACE A CONFLICT OF INTEREST POLICY THAT IS MONITORED REGULARLY. EXCERPTS FROM THE POLICY RELATED TO THIS QUESTION ARE SHOWN BELOW: THE CONFLICT OF INTEREST POLICY OF ADVAMED: (1) DEFINES CONFLICTS OF INTEREST; (2) IDENTIFIES CLASSES OF INDIVIDUALS WITHIN THE ASSOCIATION COVERED BY THIS POLICY; (3) FACILITATES DISCLOSURE OF INFORMATION THAT MAY HELP IDENTIFY CONFLICTS OF INTEREST; AND (4) SPECIFIES PROCEDURES TO BE FOLLOWED IN MANAGING CONFLICTS OF INTEREST. 1. A CONFLICT OF INTEREST ARISES WHEN A PERSON IN A POSITION OF AUTHORITY OVER THE ASSOCIATION MAY BENEFIT FINANCIALLY FROM A DECISION HE OR SHE COULD MAKE IN THAT CAPACITY, INCLUDING INDIRECT BENEFITS SUCH AS TO FAMILY MEMBERS OR BUSINESSES WITH WHICH THE PERSON IS CLOSELY ASSOCIATED. ADVAMED'S POLICY IS FOCUSED UPON MATERIAL FINANCIAL INTEREST OF, OR BENEFIT TO, SUCH PERSONS. 2. PERSONS COVERED BY THIS POLICY ARE THE ASSOCIATION'S STAFF OFFICERS, DIRECTORS, CHIEF EXECUTIVE OFFICER, AND CHIEF ADMINISTRATIVE OFFICER. 3. PERSONS COVERED BY THIS POLICY ANNUALLY DISCLOSE TO THE GENERAL COUNSEL ON A FORM PROVIDED BY THE ASSOCIATION THEIR INTERESTS THAT COULD GIVE RISE TO CONFLICTS OF INTEREST, SUCH AS A LIST OF FAMILY MEMBERS, SUBSTANTIAL BUSINESS OR INVESTMENT HOLDINGS, AND OTHER TRANSACTIONS OR AFFILIATIONS WITH BUSINESSES AND OTHER ORGANIZATIONS OR THOSE OF FAMILY MEMBERS. 4. FOR EACH INTEREST DISCLOSED TO THE GENERAL COUNSEL, THE GENERAL COUNSEL WILL DETERMINE WHETHER TO: (A) TAKE NO ACTION; (B) ASSURE FULL DISCLOSURE TO THE BOARD OF DIRECTORS AND OTHER INDIVIDUALS COVERED BY THIS POLICY; (C) ASK THE PERSON TO RECUSE FROM PARTICIPATION IN RELATED DISCUSSIONS OR DECISIONS WITHIN THE ASSOCIATION; OR (D) ASK THE PERSON TO RESIGN FROM HIS OR HER POSITION IN THE ASSOCIATION OR, IF THE PERSON REFUSES TO RESIGN, BECOME SUBJECT TO POSSIBLE REMOVAL IN ACCORDANCE WITH THE ASSOCIATION'S REMOVAL PROCEDURES. THE ASSOCIATION'S CHIEF ADMINISTRATIVE OFFICER AND VICE PRESIDENT OF FINANCE WILL MONITOR PROPOSED OR ONGOING TRANSACTIONS FOR CONFLICTS OF INTEREST AND DISCLOSE THEM TO THE CHAIRMAN OF THE BOARD OF DIRECTORS IN ORDER TO DEAL WITH POTENTIAL OR ACTUAL CONFLICTS, WHETHER DISCOVERED BEFORE OR AFTER THE TRANSACTION HAS OCCURRED. INTERESTS IN MEMBER COMPANIES: AT TIMES, ADVAMED STAFF AND/OR DIRECTORS MAY BE AWARE OF THE SIGNIFICANT AMOUNT OF INTEREST GENERATED IN CONNECTION WITH NEW PRODUCT DEVELOPMENT, SALES AND PROFITS, PRODUCT REGULATORY STATUS, AND ACQUISITIONS IN THE HEALTH CARE TECHNOLOGY INDUSTRY. THUS, ANYONE IN POSSESSION OF MATERIAL INFORMATION NOT GENERALLY AVAILABLE TO THE INVESTING PUBLIC MUST, IN ORDER TO COMPLY WITH THIS POLICY, EITHER DISCLOSE THAT KNOWLEDGE OR REFRAIN FROM TRADING IN THE STOCK. IN ADDITION, THE PURCHASE OF STOCK IN MEMBER COMPANIES CAN LEAD TO THE APPEARANCE THAT A MEMBER OF THE STAFF AND/OR BOARD OF DIRECTORS IS FAVORING THE INTERESTS OF THAT COMPANY BECAUSE OF SUCH FINANCIAL INTEREST. EVEN IF THERE IS NO ACTUAL CONFLICT OF INTEREST, THE APPEARANCE OF IMPROPRIETY MUST BE AVOIDED. NO EMPLOYEE OF THE ASSOCIATION OR MEMBER OF ITS BOARD OF DIRECTORS, EITHER IN HIS OR HER OWN NAME, OR IN THE NAME OF HIS OR HER SPOUSE OR CHILDREN, MAY PURCHASE STOCK IN ANY MEMBER COMPANY WITHOUT ADVISING THE ASSOCIATION PRESIDENT OF SUCH OWNERSHIP OR CONTEMPLATED OWNERSHIP. IN 2010, ADVAMED REQUIRED EMPLOYEES AND DIRECTORS TO SUBMIT AN ANNUAL FINANCIAL DISCLOSURE STATEMENT TO THE GENERAL COUNSEL REGARDING HOLDINGS IN MEMBER COMPANIES. AFTER REVIEW OF THE COMPLETED FORMS BY THE GENERAL COUNSEL, POTENTIAL CONFLICTS ARE REPORTED TO THE PRESIDENT, WHO REPORTS ANY SUCH DISCLOSURES TO THE CHAIRMAN OF THE BOARD OF DIRECTORS. INTERESTS IN ENTITIES DOING BUSINESS WITH ADVAMED: IN THE COURSE OF ITS DAY-TO-DAY OPERATIONS, ADVAMED CONTRACTS WITH NUMEROUS FIRMS THAT PROVIDE GOODS AND SERVICES. IT IS IMPORTANT THAT THESE FIRMS ARE CHOSEN FOR BUSINESS PURPOSES AND NOT BECAUSE THEY ARE INAPPROPRIATELY FAVORED BY ADVAMED EMPLOYEES OR DIRECTORS WHO MAY HAVE A FINANCIAL INTEREST IN PARTICULAR TRANSACTIONS. ACCORDINGLY, ADVAMED EMPLOYEES AND DIRECTORS MUST DISCLOSE, ON AN ONGOING BASIS, ANY FINANCIAL INTEREST IN A COMPANY WITH WHICH ADVAMED CONTRACTS, OR IS CONSIDERING. FORM 990, PART VI, SECTION B, LINE 15 THE PROCESS INCLUDES ALL OF THESE ELEMENTS: (1) REVIEW AND APPROVAL BY THE BOARD COMMITTEE ON FINANCE, AUDIT AND COMPENSATION OF THE ASSOCIATION; (2) USE OF DATA AS TO COMPARABLE COMPENSATION; AND (3) CONTEMPORANEOUS DOCUMENTATION AND RECORDKEEPING. 1. REVIEW AND APPROVAL. THE COMPENSATION OF THE PERSON IS REVIEWED AND APPROVED BY THE BOARD COMMITTEE ON FINANCE, AUDIT AND COMPENSATION OF THE ASSOCIATION, PROVIDED THAT PERSONS WITH CONFLICTS OF INTEREST WITH RESPECT TO THE COMPENSATION ARRANGEMENT AT ISSUE ARE NOT INVOLVED IN THIS REVIEW AND APPROVAL. 2. USE OF DATA AS TO COMPARABLE COMPENSATION. THE COMPENSATION OF THE PERSON IS REVIEWED AND APPROVED USING DATA AS TO COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS. 3. CONTEMPORANEOUS DOCUMENTATION AND RECORDKEEPING. THERE IS CONTEMPORANEOUS DOCUMENTATION AND RECORDKEEPING WITH RESPECT TO THE DELIBERATIONS AND DECISIONS REGARDING THE COMPENSATION ARRANGEMENT. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE UPON REQUEST. FORM 990, PART VI, LINE 16A THE ASSOCIATION FORMED A LIMITED LIABILITY COMPANY CALLED MEDTECH CONFERENCE PARTNERS, LLC WITH LIFE SCIENCES CONFERENCE GROUP LLC (LSCG) TO OWN AND OPERATE THE ANNUAL CONFERENCE. OTHER FEES FORM 990, PART IX, LINE 11G CONSULTING: TOTAL EXPENSES 3,505,177. OTHER PROFESSIONAL SERVICES: TOTAL EXPENSES 1,321,676. FORM 990, PART XII, LINE 2C THE PROCESS FOR OVERSEEING THE AUDIT OF THE FINANCIAL STATEMENTS AND SELECTION OF AN INDEPENDENT ACCOUNTANT THAT AUDITED THE FINANCIAL STATEMENTS HAS BEEN CONSISTENT WITH PRIOR YEARS. INSTITUTE FOR HEALTH TECHNOLOGY STUDIES 1319 F STREET NW STE 900 WASHINGTON DC 20004 522281033 PROVIDE SUPPORT FOR MEDICAL DEVICE RESEARCH DC 501(C)(3) LINE 11A, I ADVANCED MEDICAL TECHNOLOGY ASSOCIATION 1 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION POLITICAL ACTION COMMITTEE 701 PENNSYLVANIA AVENUE NW STE 800 WASHINGTON DC 20004 POLITICAL ACTION COMMITTEE DC 527 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION 1 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION CA PAC 701 PENNSYLVANIA AVENUE NW STE 800 WASHINGTON DC 20004 455309081 POLITICAL ACTION COMMITTEE DC 527 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION 1 MEDTECH CONFERENCE PARTNERS LLC 701 PENNSYLVANIA AVENUE NW STE 800 WASHINGTON DC 20004 364725626 TRADE SHOW DC ADVANCED MEDICAL TECHNOLOGY ASSOCIATION RELATED 409415 49226 1 1 0.85000 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 1 INSTITUTE FOR HEALTH TECHNOLOGY STUDIES Q 533574 CASH MEDTECH CONFERENCE PARTNERS LLC S 408349 CASH